Cargando…
Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal
Background: Lichen planus is a chronic mucocutaneous inflammatory disease. Oral manifestations are common, and may remain exclusive to the oral mucosa without involvement of the skin or other mucosae. A differential diagnosis includes oral lichenoid drug reactions. Allopurinol, which is the first li...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583598/ https://www.ncbi.nlm.nih.gov/pubmed/32806618 http://dx.doi.org/10.3390/dermatopathology7010004 |
_version_ | 1783599424607354880 |
---|---|
author | Perez, Alexandre Lazzarotto, Benjamin Carrel, Jean-Pierre Lombardi, Tommaso |
author_facet | Perez, Alexandre Lazzarotto, Benjamin Carrel, Jean-Pierre Lombardi, Tommaso |
author_sort | Perez, Alexandre |
collection | PubMed |
description | Background: Lichen planus is a chronic mucocutaneous inflammatory disease. Oral manifestations are common, and may remain exclusive to the oral mucosa without involvement of the skin or other mucosae. A differential diagnosis includes oral lichenoid drug reactions. Allopurinol, which is the first line hypo-uricemic treatment, is often quoted as being a possible offending drug, though oral reactions have rarely been reported. Case presentation: We describe a 59-year-old male gout patient, successfully treated with allopurinol, who developed acute onset of oral lichenoid lesions, involving bilaterally the buccal mucosa, the tongue and the labial mucosa. Histopathology was consistent with a lichen planus or a drug-induced lichenoid reaction. Improvement of the patient’s condition after withdrawal of allopurinol confirmed the lichenoid nature of the lesion. Remission was complete after a few weeks. Discussion: Although unusual, allopurinol may induce a lichenoid drug reaction. These reactions may mimic clinically and histopathologically idiopathic lichen planus. Improvement or complete regression of the lesions may be attempted to confirm the diagnosis. According to the latest WHO recommendations, these lesions have a potential for malignant transformation. |
format | Online Article Text |
id | pubmed-7583598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75835982020-10-28 Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal Perez, Alexandre Lazzarotto, Benjamin Carrel, Jean-Pierre Lombardi, Tommaso Dermatopathology (Basel) Case Report Background: Lichen planus is a chronic mucocutaneous inflammatory disease. Oral manifestations are common, and may remain exclusive to the oral mucosa without involvement of the skin or other mucosae. A differential diagnosis includes oral lichenoid drug reactions. Allopurinol, which is the first line hypo-uricemic treatment, is often quoted as being a possible offending drug, though oral reactions have rarely been reported. Case presentation: We describe a 59-year-old male gout patient, successfully treated with allopurinol, who developed acute onset of oral lichenoid lesions, involving bilaterally the buccal mucosa, the tongue and the labial mucosa. Histopathology was consistent with a lichen planus or a drug-induced lichenoid reaction. Improvement of the patient’s condition after withdrawal of allopurinol confirmed the lichenoid nature of the lesion. Remission was complete after a few weeks. Discussion: Although unusual, allopurinol may induce a lichenoid drug reaction. These reactions may mimic clinically and histopathologically idiopathic lichen planus. Improvement or complete regression of the lesions may be attempted to confirm the diagnosis. According to the latest WHO recommendations, these lesions have a potential for malignant transformation. MDPI 2020-08-12 /pmc/articles/PMC7583598/ /pubmed/32806618 http://dx.doi.org/10.3390/dermatopathology7010004 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Perez, Alexandre Lazzarotto, Benjamin Carrel, Jean-Pierre Lombardi, Tommaso Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal |
title | Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal |
title_full | Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal |
title_fullStr | Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal |
title_full_unstemmed | Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal |
title_short | Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal |
title_sort | allopurinol-induced oral lichenoid drug reaction with complete regression after drug withdrawal |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583598/ https://www.ncbi.nlm.nih.gov/pubmed/32806618 http://dx.doi.org/10.3390/dermatopathology7010004 |
work_keys_str_mv | AT perezalexandre allopurinolinducedorallichenoiddrugreactionwithcompleteregressionafterdrugwithdrawal AT lazzarottobenjamin allopurinolinducedorallichenoiddrugreactionwithcompleteregressionafterdrugwithdrawal AT carreljeanpierre allopurinolinducedorallichenoiddrugreactionwithcompleteregressionafterdrugwithdrawal AT lombarditommaso allopurinolinducedorallichenoiddrugreactionwithcompleteregressionafterdrugwithdrawal |